北京安泰生物医用材料有限公司（以下简称安泰生物）,成立于1988年，是由原冶金部钢铁研究总院物理室（13室）发展而来，是原钢铁研究总院成立的企业之一，也是原北京市高新技术产业试验区重点企业。2003年重新注册为北京安泰生物医用材料有限公司，公司注册资本为2900万元人民币，研发生产中心位于中关村永丰新材料产业基地。
Beijing Antai Biomaterials Co., Ltd (ATBIO), established in 18, was one of the companies transformed from China Iron & Steel Research Institute Group (CISRI), and one of the Beijing high-tech industrial companies. ATBIO has registered capital 29,000,000, RMB and the R&D center is located in ZhongGuanCun YongFeng National Independent Innovation Industrial Park.
安泰生物现有职工87人，其中博士5人，硕士7人，本科及以上人员共计28人，占员工总人数的30%，研发人员16人，占员工总人数的17%。专业覆盖金属、高分子、无机非金属材料、机电和生物化学专业。
ATBIO has 87 employees, including 5 doctors or post-doctoral professionals, 7 staffs with master degrees and 16 with bachelor degrees, accounting for 30% of the total member of the employees. The R&D center has 16 staffs, accounting for 17% of the total. They specialize in physics, chemistry, material, and metallurgy etc.
作为从事生物医用材料的研发、生产与经营的专业公司，拥有“口腔数字化医疗技术和材料”工程实验室和北京市口腔材料工程技术研究中心，通过ISO9000和ISO1348、YY/T 0287医疗器械质量管理体系认证，产品拥有CFDA产品注册证及CE、FDA认证；其中口腔领域纳米树脂、银合金粉、新型介入性治疗支架等多项产品获北京自主创新产品证书。2013年，公司顺利通过生产标准化二级单位评定。经过多年发展，安泰生物共申请21项发明和实用新型专利，授权专利18项，其中发明专利14项。
Focusing its business on R&D and manufacture of new bio-materials and products, ATBIO owns the National Engineering Laboratory for Dental Digitization and Medical Treatment Technology and Material and Beijing Dental Materials Engineering Research Center. ATBIO has passed the ISO9000 and ISO13485/YY0287 certification. The products have CFDA and CE\FDA certifications. In 2013, ATBIO has passed the Safety production standardization grade 2. Up to now, ATBIO has owned 21 patents, including 14 patents of invention.